Group Companies Commend 2019 Advanced
Release time:
2020-07-15
On the afternoon of January 20, the Group Company held the 2019 Annual Summary and Commendation Conference to review the work of the previous year, make arrangements for the work of 2019, solemnly commend the advanced collectives and individuals of 2019, and sign the 2020 Economic Responsibility System with various professional companies and directly affiliated enterprises.
2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. The company's enterprises have carried out their work around the general policy of "innovation and reform, integration and improvement, scientific layout and steady development", and have achieved good business performance on the whole, making a good start for the new five-year plan. At the summary and commendation meeting, Yu Jianhong, general manager of the group company, made a work report entitled "Breaking through self, creating advantages, and creating a new situation of peak and high-quality development" and made substantial progress in the construction of key investment projects. Continue to carry out in-depth management integration and effectively improve the management level. New achievements have been made in scientific and technological innovation and technological transformation. Innovate marketing forms and strengthen marketing management and market expansion; progress has been made in safety risk assessment and safety and environmental protection management; party building, ideological and political work, and corporate culture work have been strengthened to enhance corporate cohesion and centripetal force; corporate image, influence and reputation have been effectively improved in eight aspects, including a comprehensive review of the work in 2019. While summing up the achievements, Yu Jianhong also pointed out that the two main businesses of the company are relatively small in scale. The profitability of assets is uneven, and the benefit growth through extension development and endogenous improvement is slow. The products of some enterprises lack market competitive advantage. The overall age of the management team is too old and there is the idea of "keeping success". Some managers have pride and complacency, and their daily management is lax; managers' ideas and ways of thinking are still relatively traditional, lack of learning and pioneering and innovative spirit, lack of crisis awareness, and lack of courage to change themselves.
combined with the spirit of the 2020 central economic work conference, after a comprehensive analysis of the current national economic situation, policies and the changing trend of the company's related industries, Yu jianhong, on behalf of the group company, put forward the 2020 work policy, "make up for the short board, improve quality and efficiency, and create core competitive advantages", and around this policy, put forward the key work in 2020: strengthen and improve the management ability of management cadres; Around strategic planning, promote enterprise development and cultivate core competitiveness; strengthen management improvement, promote management reform, and enhance core competitiveness; improve the pharmaceutical research and development system and enhance research and development capabilities; increase technological innovation and technological upgrading, continue to improve production efficiency and product quality, and enhance enterprises Competitive strength; improve the incentive mechanism, pay attention to training investment, and further strengthen human resource development; continue to work hard to manage safety and environmental protection; grasp market trends and create market advantages, improve the sustainable profitability of products; further strengthen the construction of the party, and constantly enrich the connotation of corporate culture.
Yu Jianhong pointed out that as far as the peak is concerned, while setting a new record in 2019, it is also standing at a higher new starting point. In the face of more severe challenges, risks and threats will occur at any time on the way forward. Hope can only rest on ourselves. He hopes that all cadres and employees will grasp the trend, face up to difficulties, be brave in change, be good at innovation, unite sincerely, and help each other in the same boat, so as to create a new era of peak and high-quality development. At the
meeting, General Manager Yu Jianhong, on behalf of the Group, signed the 2020 economic responsibility system with Daye Peak, Yunnan Peak, Pharmaceutical Company, Health Technology Company, International Trading Company and Cable Company. Huang Jinlong, deputy general manager of the group company and chairman of Shanghai North Carolina Company, signed a responsibility system with the management team on behalf of the Shanghai North Carolina board of directors.
Xiang Chongping, deputy general manager of the group company, read out the list of advanced collectives and individuals of the group company in 2019 at the conference. In the warm atmosphere, the company's advanced red hanging lottery on stage to receive the award. Wu Weisheng, representative of the advanced party organization and secretary of the general party branch of Jinhua pharmaceutical company, Wang Yiyan, representative of outstanding employees and Daye peak, Zhang Baoping, representative of outstanding management workers and deputy director of peak pharmaceutical factory, Li Haiyu, representative of outstanding salesmen and representative of Daye peak Wuhan office, took the stage to speak respectively, reviewing the gains and losses of the past year's work and sharing experiences and experiences.
Jiang Xiaomeng, Secretary of the Party Committee and Chairman of the Group Company, made a concluding speech at the meeting. In his speech, Jiang Xiaomeng, on behalf of the group's party committee and board of directors, congratulated the advanced collectives and individuals who were commended, and thanked all the peak employees for their hard work and the best performance in history. In response to the market situation and existing problems faced by the company that year, Jiang Xiaomeng proposed that management teams and business backbones at all levels must fully understand and understand the trend of environmental changes, and further enhance risk awareness; break through the management framework with transformational thinking and further improve corporate profitability Ability; to further emphasize responsibility and the spirit of responsibility, especially management cadres at all levels should take their own responsibilities and set a good example; to further accelerate project construction, to build the company's future growth pole; to pay more attention to party building work, strengthen self-discipline, strict compliance. He hopes that all employees will continue to be full of spirit in the new year to bring all kinds of work to a higher level and achieve new breakthroughs. (this newspaper reporter)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31